会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Methods and apparatus for automatically tracking heart failure status
    • 自动跟踪心力衰竭状态的方法和装置
    • US08249709B2
    • 2012-08-21
    • US13037817
    • 2011-03-01
    • Lynn A. DavenportPurvee P. ParikhTodd J. Sheldon
    • Lynn A. DavenportPurvee P. ParikhTodd J. Sheldon
    • A61N1/37
    • A61N1/3627
    • Assessing symptomatic and asymptomatic physiologic changes due to chronic heart failure involves apparatus and methods for gauging degradation and possible improvement using automated measurement of inter-ventricular conduction time, both alone and in combination with other automated physiologic tests. Conduction times increase due to the greater distance a wavefront must traverse as a heart enlarges. Analysis of conduction time can be used to verify the occurrence of cardiac remodeling due to heart failure as well as beneficial reverse remodeling due to successful heart failure therapy delivery. Patient activity level(s) and presence/increase in pulmonary fluids can also be used to automatically determine changes in heart failure status and/or predict hospitalization. Conduction time is monitored between electrodes positioned in the left and right ventricles of the heart via endocardial or epicardial electrodes.
    • 评估因慢性心力衰竭引起的症状和无症状的生理变化涉及用于测量降解的设备和方法,并且可以通过自动测量心室间传导时间来单独测量并与其他自动化生理测试结合使用。 由于随着心脏的扩大,波前必须穿越的距离越大,传导时间就会增加。 传导时间分析可以用于验证由于心力衰竭导致的心脏重构的发生以及由于成功的心力衰竭治疗递送而导致的有益的反向重建。 患者活动水平和肺流体的存在/增加也可用于自动确定心力衰竭状态的变化和/或预测住院治疗。 通过心内膜或心外膜电极监测位于心脏左心室和右心室的电极之间的传导时间。
    • 2. 发明申请
    • METHODS AND APPARATUS FOR AUTOMATICALLY TRACKING HEART FAILURE STATUS
    • 自动跟踪心脏失败状态的方法和装置
    • US20110152660A1
    • 2011-06-23
    • US13037817
    • 2011-03-01
    • Lynn A. DavenportPurvee P. ParikhTodd J. Sheldon
    • Lynn A. DavenportPurvee P. ParikhTodd J. Sheldon
    • A61B5/044A61B5/042
    • A61N1/3627
    • Assessing symptomatic and asymptomatic physiologic changes due to chronic heart failure involves apparatus and methods for gauging degradation and possible improvement using automated measurement of inter-ventricular conduction time, both alone and in combination with other automated physiologic tests. Conduction times increase due to the greater distance a wavefront must traverse as a heart enlarges. Analysis of conduction time can be used to verify the occurrence of cardiac remodeling due to heart failure as well as beneficial reverse remodeling due to successful heart failure therapy delivery. Patient activity level(s) and presence/increase in pulmonary fluids can also be used to automatically determine changes in heart failure status and/or predict hospitalization. Conduction time is monitored between electrodes positioned in the left and right ventricles of the heart via endocardial or epicardial electrodes.
    • 评估因慢性心力衰竭引起的症状和无症状的生理变化涉及用于测量降解的设备和方法,并且可以通过自动测量心室间传导时间来单独测量并与其他自动化生理测试结合使用。 由于随着心脏的扩大,波前必须穿越的距离越大,传导时间就会增加。 传导时间分析可以用于验证由于心力衰竭导致的心脏重构的发生以及由于成功的心力衰竭治疗递送而导致的有益的反向重建。 患者活动水平和肺流体的存在/增加也可用于自动确定心力衰竭状态的变化和/或预测住院治疗。 通过心内膜或心外膜电极监测位于心脏左心室和右心室的电极之间的传导时间。
    • 3. 发明申请
    • METHODS AND APPARATUS FOR AUTOMATICALLY TRACKING HEART FAILURE STATUS
    • 自动跟踪心脏失败状态的方法和装置
    • US20070288059A1
    • 2007-12-13
    • US11691266
    • 2007-03-26
    • Lynn A. DavenportPurvee P. ParikhTodd J. Sheldon
    • Lynn A. DavenportPurvee P. ParikhTodd J. Sheldon
    • A61N1/362
    • A61N1/3627
    • Assessing symptomatic and asymptomatic physiologic changes due to chronic heart failure involves apparatus and methods for gauging degradation and possible improvement using automated measurement of inter-ventricular conduction time, both alone and in combination with other automated physiologic tests. Conduction times increase due to the greater distance a wavefront must traverse as a heart enlarges. Analysis of conduction time can be used to verify the occurrence of cardiac remodeling due to heart failure as well as beneficial reverse remodeling due to successful heart failure therapy delivery. Patient activity level(s) and presence/increase in pulmonary fluids can also be used to automatically determine changes in heart failure status and/or predict hospitalization. Conduction time is monitored between electrodes positioned in the left and right ventricles of the heart via endocardial or epicardial electrodes.
    • 评估因慢性心力衰竭引起的症状和无症状的生理变化涉及用于测量降解的设备和方法,并且可以通过自动测量心室间传导时间来单独测量并与其他自动化生理测试结合使用。 由于随着心脏的扩大,波前必须穿越的距离越大,传导时间就会增加。 传导时间分析可以用于验证由于心力衰竭导致的心脏重构的发生以及由于成功的心力衰竭治疗递送而导致的有益的反向重建。 患者活动水平和肺流体的存在/增加也可以用于自动确定心力衰竭状态的变化和/或预测住院治疗。 通过心内膜或心外膜电极监测位于心脏左心室和右心室的电极之间的传导时间。
    • 7. 发明授权
    • Methods and apparatus for automatically tracking heart failure status
    • 自动跟踪心力衰竭状态的方法和装置
    • US07899538B2
    • 2011-03-01
    • US11691266
    • 2007-03-26
    • Lynn A. DavenportPurvee P. ParikhTodd J. Sheldon
    • Lynn A. DavenportPurvee P. ParikhTodd J. Sheldon
    • A61N1/37
    • A61N1/3627
    • Assessing symptomatic and asymptomatic physiologic changes due to chronic heart failure involves apparatus and methods for gauging degradation and possible improvement using automated measurement of inter-ventricular conduction time, both alone and in combination with other automated physiologic tests. Conduction times increase due to the greater distance a wavefront must traverse as a heart enlarges. Analysis of conduction time can be used to verify the occurrence of cardiac remodeling due to heart failure as well as beneficial reverse remodeling due to successful heart failure therapy delivery. Patient activity level(s) and presence/increase in pulmonary fluids can also be used to automatically determine changes in heart failure status and/or predict hospitalization. Conduction time is monitored between electrodes positioned in the left and right ventricles of the heart via endocardial or epicardial electrodes.
    • 评估因慢性心力衰竭引起的症状和无症状的生理变化涉及用于测量降解的设备和方法,并且可以通过自动测量心室间传导时间来单独测量并与其他自动化生理测试结合使用。 由于随着心脏的扩大,波前必须穿越的距离越大,传导时间就会增加。 传导时间分析可以用于验证由于心力衰竭导致的心脏重构的发生以及由于成功的心力衰竭治疗递送而导致的有益的反向重建。 患者活动水平和肺流体的存在/增加也可用于自动确定心力衰竭状态的变化和/或预测住院治疗。 通过心内膜或心外膜电极监测位于心脏左心室和右心室的电极之间的传导时间。
    • 9. 发明申请
    • PERFORMING EXTENDED CAPTURE DETECTION TEST AFTER DETECTING INADEQUATE CAPTURE
    • 在检测到不正确的捕获后执行扩展捕获检测测试
    • US20100198295A1
    • 2010-08-05
    • US12362905
    • 2009-01-30
    • Todd SheldonLynn A. Davenport
    • Todd SheldonLynn A. Davenport
    • A61N1/37
    • A61N1/371
    • Techniques are described for performing an extended capture detection test after detecting inadequate capture during a first capture detection test. An example system includes an implantable medical device that delivers pacing pulses to a patient, that periodically performs a first capture detection test to detect capture or loss of capture of the pacing pulses, and that detects inadequate capture during the first capture detection test, wherein in response to detecting the inadequate capture, the implantable medical device performs a second capture detection test that is longer than the first test. The system also includes a programmer device that programs the implantable medical device and that retrieves data from the implantable medical device corresponding to the second capture detection test. The example system may conserve battery power and prevent loss of current by performing the extended capture detection test only after detection of inadequate capture during the first test.
    • 描述了在第一捕获检测测试中检测到不充分捕获之后进行扩展捕获检测测试的技术。 示例性系统包括向患者传送起搏脉冲的可植入医疗装置,其周期性地执行第一捕获检测测试以检测起搏脉冲的捕获或丢失,并且在第一捕获检测测试期间检测不充分的捕获,其中 响应于检测到不充分的捕获,可植入医疗装置执行比第一测试更长的第二捕获检测测试。 该系统还包括编程器设备,其对可植入医疗设备进行编程,并从与第二捕获检测测试相对应的可植入医疗设备中检索数据。 该示例系统可以仅在第一次测试中检测到不充分的捕获之后执行扩展捕获检测测试来节省电池电力并防止电流损失。